Elite Pharma Inc
OTCPK:ELTP
United States / Healthcare / Pharmaceuticals
ELTP News
Welcome to Your News Upgrade
Be the First to Know and Act on Market Moving News.
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
Northvale, New Jersey--(Newsfile Corp. - March 3, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche...
Earnings call transcript: Elite Pharma's Q3 2024 revenue dips 8%, stock falls 9.96%
Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information
Conference Call Scheduled for Friday, February 14 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - February 13, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite"...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025
Financials for the Third Quarter of Fiscal Year 2025 Ended December 31, 2024 will be released on Thursday, February 13, 2025 Northvale, New Jersey--(Newsfile Corp. - February 10,...
Elite Pharmaceuticals launches generic ADHD medication
NORTHVALE, NJ - Elite Pharmaceuticals, Inc. (OTCQB: ELTP), a specialty pharmaceutical company with a market capitalization of $571.58 million, announced the release of a generic...
Elite Pharmaceuticals, Inc. Announces Commercial Launch of Generic Vyvanse
Elite Pharmaceuticals, Inc. (ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched...
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
Northvale, New Jersey--(Newsfile Corp. - December 2, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing...
Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
Elite Pharmaceuticals, Inc. (ELTP) today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) for a...
Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in...
Earnings call: Elite Pharmaceuticals posts robust Q2 growth, eyes future
Elite Pharmaceuticals Inc. (ticker: ELTP) reported a strong financial performance in its second quarter conference call for the fiscal year 2025, with CEO Nasrat Hakim and CFO...